Patent · US Active

Treatment of schizophrenia and related disorders

US8252801B1 · kind B1 · utility

0Cited by
9References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 3, 2010
Grant dateAug 28, 2012
Priority date
Expiry dateJul 6, 2030

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K45/06
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to a method of administering histamine H3 antagonist and an antipsychotic therapeutic agent, compositions comprising a histamine H3 antagonist and an antipsychotic therapeutic agent, and a related article of manufacture.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.